ES312253A1 - Procedure for forming a film coating, for pharmaceutical dose units. (Machine-translation by Google Translate, not legally binding) - Google Patents

Procedure for forming a film coating, for pharmaceutical dose units. (Machine-translation by Google Translate, not legally binding)

Info

Publication number
ES312253A1
ES312253A1 ES0312253A ES312253A ES312253A1 ES 312253 A1 ES312253 A1 ES 312253A1 ES 0312253 A ES0312253 A ES 0312253A ES 312253 A ES312253 A ES 312253A ES 312253 A1 ES312253 A1 ES 312253A1
Authority
ES
Spain
Prior art keywords
cores
translation
machine
forming
legally binding
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
ES0312253A
Other languages
Spanish (es)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Merck and Co Inc
Original Assignee
Merck and Co Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merck and Co Inc filed Critical Merck and Co Inc
Publication of ES312253A1 publication Critical patent/ES312253A1/en
Expired legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/13—Amines
    • A61K31/14—Quaternary ammonium compounds, e.g. edrophonium, choline
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose

Abstract

Process for forming a coating in the form of a film, for pharmaceutical, continuous and non-toxic dosage units, on a plurality of shaped cores that contain at least one pharmaceutical ingredient, comprising the steps of (1) setting in motion said cores , (2) continuously spraying said mobile cores with an atomized solution of a compound selected from the class consisting of hydroxypropyl methyl cellulose and methyl cellulose in substantially equal amounts of ethanol and chloroform (3) continuously evaporating said ethanol and chloroform from said cores as well sprayed, with a speed such that said cores maintain a substantially dry appearance, and (4) continue the simultaneous rolling, spraying and evaporation until a continuous film is established on said shaped cores. (Machine-translation by Google Translate, not legally binding)
ES0312253A 1964-04-17 1965-04-15 Procedure for forming a film coating, for pharmaceutical dose units. (Machine-translation by Google Translate, not legally binding) Expired ES312253A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US360772A US3383236A (en) 1964-04-17 1964-04-17 Continuous pharmaceutical film coating process

Publications (1)

Publication Number Publication Date
ES312253A1 true ES312253A1 (en) 1966-02-16

Family

ID=23419346

Family Applications (1)

Application Number Title Priority Date Filing Date
ES0312253A Expired ES312253A1 (en) 1964-04-17 1965-04-15 Procedure for forming a film coating, for pharmaceutical dose units. (Machine-translation by Google Translate, not legally binding)

Country Status (11)

Country Link
US (1) US3383236A (en)
BE (1) BE661581A (en)
BR (1) BR6566503D0 (en)
DE (1) DE1492029A1 (en)
ES (1) ES312253A1 (en)
FR (1) FR1455065A (en)
GB (1) GB1059508A (en)
IL (1) IL22778A (en)
NL (1) NL6502190A (en)
NO (1) NO117494B (en)
SE (1) SE352531B (en)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3524756A (en) * 1967-05-29 1970-08-18 Colorcon Process of coating tablets with alternate tacky and non-tacky layers
US3486951A (en) * 1967-06-16 1969-12-30 Corning Glass Works Method of manufacturing semiconductor devices
US3539380A (en) * 1968-01-08 1970-11-10 Upjohn Co Methylcellulose and polyalkylene glycol coating of solid medicinal dosage forms
US3900583A (en) * 1971-08-10 1975-08-19 American Home Prod Contoured belt coating method
US3919436A (en) * 1971-09-27 1975-11-11 Eisai Co Ltd Process for preparation of coated medicines
JPS50129727A (en) * 1974-04-04 1975-10-14
US4140756A (en) * 1976-06-10 1979-02-20 Mead Johnson & Company Film-coated matrix core tablet
US4173626A (en) 1978-12-11 1979-11-06 Merck & Co., Inc. Sustained release indomethacin
JPS5620513A (en) * 1979-07-31 1981-02-26 Eisai Co Ltd Sugar-coated tablet containing fat-soluble drug
US4302440B1 (en) * 1980-07-31 1986-08-05 Easily-swallowed, powder-free and gastric-disintegrable aspirin tablet thinly-coated with hydroxypropyl methylcellulose and aqueous spray-coating preparation thereof
US4508702A (en) * 1982-06-14 1985-04-02 Key Pharmaceuticals, Inc. Sustained release aspirin
DE3236192A1 (en) 1982-09-30 1984-04-05 Dr. Karl Thomae Gmbh, 7950 Biberach CONTROLLED AND REGULATED PROCEDURE FOR FULLY AUTOMATIC, CONTINUOUS DRAGING
US4555399A (en) * 1983-11-18 1985-11-26 Key Pharmaceuticals, Inc. Aspirin tablet
GB8524001D0 (en) * 1985-09-30 1985-11-06 Glaxo Group Ltd Pharmaceutical composition
US4795032A (en) * 1987-12-04 1989-01-03 S. C. Johnson & Son, Inc. Wash-added, rinse-activated fabric conditioner and package
US4970008A (en) * 1988-12-20 1990-11-13 Kandathil Thomas V Fabric conditioner comprising a mixture of quaternary ammonium compounds and select tertiary amines
CA2011684C (en) * 1989-07-31 2000-05-02 Lawrence J. Daher Aqueous film coating
WO2000027849A2 (en) 1998-11-12 2000-05-18 Merck & Co., Inc. Therapeutic polymorphs of a gaba-a alpha-5 inverse agonist and pamoate formulations of the same
US6733780B1 (en) 1999-10-19 2004-05-11 Genzyme Corporation Direct compression polymer tablet core
US20020054903A1 (en) * 1999-10-19 2002-05-09 Joseph Tyler Direct compression polymer tablet core
US7985418B2 (en) 2004-11-01 2011-07-26 Genzyme Corporation Aliphatic amine polymer salts for tableting
US20060177415A1 (en) * 2004-11-01 2006-08-10 Burke Steven K Once a day formulation for phosphate binders
US8986669B2 (en) * 2005-09-02 2015-03-24 Genzyme Corporation Method for removing phosphate and polymer used therefore
JP5595660B2 (en) 2005-09-15 2014-09-24 ジェンザイム コーポレーション Sachet formulation for amine polymer
WO2007130463A2 (en) * 2006-05-05 2007-11-15 Genzyme Corporation Amine condensation polymers as phosphate sequestrants
CA2658338A1 (en) * 2006-07-18 2008-01-24 Genzyme Corporation Amine dendrimers
US8425887B2 (en) 2006-09-29 2013-04-23 Genzyme Corporation Amide dendrimer compositions
JP2010513271A (en) * 2006-12-14 2010-04-30 ゲンズイメ コーポレーション Amide-amine polymer composition
US20100129309A1 (en) * 2007-02-23 2010-05-27 Dhal Pradeep K Amine polymer compositions
JP2010520285A (en) * 2007-03-08 2010-06-10 ゲンズイメ コーポレーション Sulfone polymer composition
JP2010525061A (en) * 2007-04-27 2010-07-22 ゲンズイメ コーポレーション Amidoamine dendrimer composition
JP2011506449A (en) * 2007-12-14 2011-03-03 ジェンザイム コーポレーション Coating pharmaceutical composition

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CA652743A (en) * 1962-11-20 Charles E. Frosst And Co. Film coating for tablets
GB978264A (en) * 1960-02-26
NL282752A (en) * 1961-09-10
US3256111A (en) * 1964-12-04 1966-06-14 Abbott Lab Method for coating tablets

Also Published As

Publication number Publication date
SE352531B (en) 1973-01-08
BR6566503D0 (en) 1973-07-17
US3383236A (en) 1968-05-14
DE1492029A1 (en) 1969-02-20
FR1455065A (en) 1966-10-14
BE661581A (en) 1965-09-24
GB1059508A (en) 1967-02-22
NL6502190A (en) 1965-10-18
IL22778A (en) 1968-08-22
NO117494B (en) 1969-08-18

Similar Documents

Publication Publication Date Title
ES312253A1 (en) Procedure for forming a film coating, for pharmaceutical dose units. (Machine-translation by Google Translate, not legally binding)
JPS5215812A (en) Process for preparing an l-ascorbic acid pharmaceutical
IL56664A0 (en) New propanone derivatives,process for producing them and pharmaceutical composition containig this derivative as active ingredient
NL163216C (en) METHOD FOR PREPARING PHARMACOLOGICALLY ACTIVE 3- (SUBSTITUTED) PHENYL-5-HYDROXYMETHYL-1,3-OXAZOLIDINONE-2-ON COMPOUNDS; PHARMACEUTICAL PREPARATION WITH DEPRESSION-PROOF AND URICOSURIC EFFECT.
BE586626A (en) New pyrazole derivatives, their preparation and pharmaceutical compositions containing them.
NL151693B (en) PROCESS FOR PREPARING A MEDICINAL PRODUCT WITH A BRONCHOSPASMOLYTIC ACTION CONTAINING A DERIVATIVE OF 2-AMINO-1- (3,5-DIHYDROXYPHENYL) ETHANOL AND OBTAINED UNDER APPLICATION OF THIS METHOD OF THE BRONCHOSPASMOLYTIC METHOD OF THE PREPARED METHOD A MEDICINAL 2-AMINO-1- (3,5-DIHYDROXYPHENYL) ETHANOL DERIVATIVE, USED AS AN ACTIVE INGREDIENT IN SUCH MEDICINAL PRODUCT.
EP0013131A3 (en) Pharmaceutical composition in solid dosage form, and process for its production
ES414425A1 (en) Process for coating finely divided medicaments
FI51704C (en) Process for the preparation of therapeutically active 4-methoxy-5,12-dioxo-6,9,11-trihydroxy-7- (0-2,3,6-tridesoxy-3-amino-1-L-lyxohexosyl) -7 -ac ethylhexahydronaphthacene derivatives and their salts.
IL30329A0 (en) New 13beta-alkyl-9beta,10alpha-pregnanes,methods of producing the same,pharmaceutical compositions comprising the new compounds as an active ingredient and a method of producing these compositions
NL160722C (en) PROCESS FOR PREPARING A PHARMACEUTICAL PREPARATION BY CONTAINING A 6,6-DIFLUORSTEROID IN A FORM SUITABLE FOR THERAPEUTIC ADMINISTRATION, AND FORMED PREPARATION AND PROCEDURE FOR PREPARING THE ACTIVE COMPOUNDS.
ES355628A1 (en) The Stabilization of Ascorbic Acid and of Derivatives thereof
ES316969A1 (en) Procedure for the obtaining of a product to redime the desire to smoking tobacco. (Machine-translation by Google Translate, not legally binding)
CA937866A (en) Process for the manufacture of a drug dosage form permitting controlled release of active ingredient
FI56770B (en) FOERFARANDE FOER FRAMSTAELLNING AV ETT TERAPEUTISKT ANVAENDBART STABILT FAST KOLINSALICYLATKOMPLEX
GB1235529A (en) Composition for mucolysis
ES469749A1 (en) Nitroimidazole composition
GB1116775A (en) ªß-hydroxy-acrylic acid derivatives and process for their manufacture
GB1072359A (en) Pyrazolone derivatives and pharmaceutical compositions containing them
JPS5375243A (en) Pattern forming
ES327141A1 (en) A method to desert a plant. (Machine-translation by Google Translate, not legally binding)
JPS51145539A (en) A spray booth
BR7204810D0 (en) NEW AND ORIGINAL ATOMIZING TURBINE NEBULIZING FOR DEFENSIVE AND SIMILAR
GB1234332A (en)
ES273779A3 (en) A method of doing pharmaceutical preparations administrables by oral (Machine-translation by Google Translate, not legally binding)